000623.SZ
吉林敖东
SZSE · Healthcare · C 制造业 · CN
CNY 17.98
+0.06%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.2B | 2.3B | 2.6B | 3.4B | 2.9B |
| Cost of Revenue | 1.1B | 1.2B | 1.6B | 1.8B | 1.4B |
| Gross Profit | 1.1B | 1.1B | 1.1B | 1.7B | 1.5B |
| Operating Expenses | |||||
| R&D Expense | 103.2M | 101.9M | 82.2M | 125.0M | 85.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 257.7M | 260.3M | 326.4M | 333.3M | 319.0M |
| Selling & Marketing Expense | 756.0M | 825.3M | 729.0M | 1.0B | 862.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.2B | 1.3B | 1.2B | 1.6B | 1.4B |
| Cost and Expenses | 2.4B | 2.5B | 2.8B | 3.4B | 2.8B |
| Operating Income (EBIT) | 2.8B | 2.4B | 1.5B | 1.4B | 1.1B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 2.8B | 2.4B | 1.5B | 1.5B | 1.7B |
| Income Tax Expense | 47.1M | 59.3M | 2.2M | 55.8M | (80.2M) |
| Bottom Line | |||||
| Net Income | 2.7B | 2.4B | 1.6B | 1.5B | 1.8B |
| Earnings from Cont. Ops | 2.7B | 2.4B | 1.5B | 1.4B | 1.8B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 2.7B | 2.4B | 1.6B | 1.5B | 1.8B |
| Per Share | |||||
| Basic EPS | CN¥2.34 | CN¥2.04 | CN¥1.32 | CN¥1.30 | CN¥1.57 |
| Diluted EPS | CN¥2.34 | CN¥2.04 | CN¥1.32 | CN¥1.23 | CN¥1.47 |
| Revenue Per Share | CN¥1.90 | CN¥1.99 | CN¥2.22 | CN¥3.06 | CN¥2.53 |
| Shares | |||||
| Basic Shares Outstanding | 1.2B | 1.2B | 1.2B | 1.1B | 1.1B |
| Diluted Shares Outstanding | 1.2B | 1.2B | 1.2B | 1.1B | 1.1B |
| Profitability Metrics | |||||
| EBITDA | — | 2.6B | 1.7B | 1.6B | 1.3B |
| D&A | — | 195.9M | 210.9M | 211.1M | 201.4M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026